This week on Simply Blood, ISEH Experimental Hematology Editorial Board member Alessandro Donada chatted with the Experimental Hematology authors Kathrin Bernt and Fatemeh Alikarami at the Division of Pediatric Oncology, Children’s Hospital of Philadelphia, USA. Watch the video to dive into their latest article, "Upfront menin-inhibitor resistance in multiply pretreated leukemias" (Open Access).

Continue the conversation on menin inhibitors by reading the newest commentary in Experimental Hematology by Brian Huntly (Cambridge Stem Cell Institute, UK) and Anjum Khan (University of York, UK), titled "Taking the direct route: menin inhibitors go straight to the frontline in KMT2A-rearranged acute leukemia".

Explore Articles on ExpHem

Blog post contributed by Alessandro Donada, PhD of the ISEH Publications Committee. 

Please note that the statements made by Simply Blood authors are their own views and not necessarily the views of ISEH. ISEH disclaims any or all liability arising from any author's statements or materials.